NO150605C - Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinyl-aminoalkyletere - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinyl-aminoalkyletereInfo
- Publication number
- NO150605C NO150605C NO780931A NO780931A NO150605C NO 150605 C NO150605 C NO 150605C NO 780931 A NO780931 A NO 780931A NO 780931 A NO780931 A NO 780931A NO 150605 C NO150605 C NO 150605C
- Authority
- NO
- Norway
- Prior art keywords
- cooleters
- aminoal
- preparation
- therapeutically active
- analogue procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0018—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C2204/00—Features not otherwise provided for
- A61C2204/002—Features not otherwise provided for using batteries
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Dentistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19772711655 DE2711655A1 (de) | 1977-03-17 | 1977-03-17 | Pyridinyl-aminoalkylaether |
Publications (3)
Publication Number | Publication Date |
---|---|
NO780931L NO780931L (no) | 1978-09-19 |
NO150605B NO150605B (no) | 1984-08-06 |
NO150605C true NO150605C (no) | 1984-11-14 |
Family
ID=6003884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO780931A NO150605C (no) | 1977-03-17 | 1978-03-16 | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinyl-aminoalkyletere |
Country Status (27)
Country | Link |
---|---|
US (1) | US4206117A (nl) |
JP (1) | JPS53116382A (nl) |
AT (2) | AT364360B (nl) |
AU (1) | AU525566B2 (nl) |
BE (1) | BE864917A (nl) |
CA (1) | CA1108148A (nl) |
CH (1) | CH638186A5 (nl) |
CS (2) | CS202011B2 (nl) |
DD (1) | DD134090A5 (nl) |
DE (1) | DE2711655A1 (nl) |
DK (1) | DK118578A (nl) |
ES (1) | ES467931A1 (nl) |
FI (1) | FI74962C (nl) |
FR (1) | FR2383930A1 (nl) |
GB (1) | GB1599061A (nl) |
GR (1) | GR64096B (nl) |
HU (1) | HU177287B (nl) |
IE (1) | IE46484B1 (nl) |
IL (1) | IL54265A0 (nl) |
IT (1) | IT1093796B (nl) |
LU (1) | LU79235A1 (nl) |
NL (1) | NL189563C (nl) |
NO (1) | NO150605C (nl) |
SE (1) | SE446185B (nl) |
SU (2) | SU799658A3 (nl) |
YU (2) | YU63678A (nl) |
ZA (1) | ZA781552B (nl) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4474781A (en) * | 1979-04-02 | 1984-10-02 | Merck & Co., Inc. | Treating hypertension with aminoalkoxypyridines |
DE3008522A1 (de) * | 1980-03-06 | 1981-09-17 | Basf Ag, 6700 Ludwigshafen | 4-(alpha)-cycloamino-arylmethyl-6-methyl-1,3-dihydro-furo (3,4-c) -pyridin-7-ole, ihre herstellung und verwendung |
IL62602A (en) * | 1980-05-19 | 1984-06-29 | Labaz Sanofi Nv | Pyridoxine derivatives,their preparation and pharmaceutical compositions containing them |
JPS588066A (ja) * | 1981-07-03 | 1983-01-18 | Otsuka Pharmaceut Co Ltd | 光学活性〔s〕−(−)−カルボスチリル誘導体の製造法 |
EP0097000B1 (en) * | 1982-06-10 | 1987-09-09 | Beecham Wuelfing GmbH & Co KG | Amine derivatives |
DE3519693A1 (de) * | 1985-06-01 | 1987-01-02 | Basf Ag | Pyridin-derivate, ihre herstellung und verwendung |
GB8603475D0 (en) * | 1986-02-12 | 1986-03-19 | Glaxo Group Ltd | Chemical compounds |
GB8703007D0 (en) * | 1987-02-10 | 1987-03-18 | Glaxo Group Ltd | Chemical compounds |
GB9012926D0 (en) * | 1990-06-09 | 1990-08-01 | Scras | Pyrrolo-pyridine derivatives |
CA2547947C (en) * | 1990-11-30 | 2007-09-25 | Masatoshi Chihiro | Azole derivatives as active superoxide radical inhibitors |
MY128323A (en) | 1996-09-30 | 2007-01-31 | Otsuka Pharma Co Ltd | Thiazole derivatives for inhibition of cytokine production and of cell adhesion |
US20010034357A1 (en) * | 2000-02-02 | 2001-10-25 | Nan-Horng Lin | Substituted pyridine compounds useful for controlling chemical synaptic transmission |
CA2521135A1 (en) * | 2003-04-07 | 2004-10-28 | Kalypsys, Inc. | N-containing heteroaromatic compounds as modulators of ppars and methods of treating metabolic disorders |
PT3135672T (pt) * | 2008-10-10 | 2020-04-02 | Vm Discovery Inc | Composições e métodos para o tratamento distúrbios de utilização de álcool, dor e outras doenças |
KR101698153B1 (ko) * | 2010-04-26 | 2017-01-23 | 광주과학기술원 | P2x1 및 p2x3 수용체 길항제로 사용되는 신규한 피리딘 카르복실산계 화합물, 이의 제조방법 및 이를 포함하는 조성물 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1572768A (en) * | 1925-06-26 | 1926-02-09 | Winthrop Chem Co Inc | Pharmaceutical product |
US1881236A (en) * | 1929-08-10 | 1932-10-04 | Soc Of Chemical Ind | Basic ethers of the pyridine series |
US3535328A (en) * | 1967-09-01 | 1970-10-20 | Exxon Research Engineering Co | Certain substituted aminothioethoxy pyridines |
AR206801A1 (es) * | 1973-02-20 | 1976-08-23 | Ciba Geigy Ag | Procedimiento para la elaboracion de derivados del 1-pirid loxi-2-hidroxi-3-amino-propano |
US4115575A (en) * | 1973-02-20 | 1978-09-19 | Ciba-Geigy Corporation | 2-(3-Amino-2-hydroxy-propoxy)-pyrazines |
US4073909A (en) * | 1973-10-08 | 1978-02-14 | Sandoz Ltd. | Isoquinoline compounds |
CH591448A5 (nl) * | 1974-05-14 | 1977-09-15 | Ciba Geigy Ag | |
CH614711A5 (nl) * | 1975-04-08 | 1979-12-14 | Sandoz Ag | |
GB1504424A (en) * | 1975-08-09 | 1978-03-22 | Beecham Group Ltd | Isoquinoline-derived aminoethers |
GB1485919A (en) | 1975-08-12 | 1977-09-14 | Grindstedvaerket As | Pyridine derivatives |
US4060601A (en) * | 1976-06-15 | 1977-11-29 | Merck & Co., Inc. | Certain lower-alkyl amino-2'-hydroxy-propoxy pyridines |
-
1977
- 1977-03-17 DE DE19772711655 patent/DE2711655A1/de active Granted
-
1978
- 1978-02-25 GR GR55546A patent/GR64096B/el unknown
- 1978-03-09 GB GB9334/78A patent/GB1599061A/en not_active Expired
- 1978-03-10 IT IT21099/78A patent/IT1093796B/it active
- 1978-03-10 US US05/885,434 patent/US4206117A/en not_active Expired - Lifetime
- 1978-03-13 IE IE503/78A patent/IE46484B1/en unknown
- 1978-03-13 NL NLAANVRAGE7802719,A patent/NL189563C/nl not_active IP Right Cessation
- 1978-03-13 IL IL54265A patent/IL54265A0/xx not_active IP Right Cessation
- 1978-03-14 SE SE7802927A patent/SE446185B/sv not_active IP Right Cessation
- 1978-03-14 CH CH278478A patent/CH638186A5/de not_active IP Right Cessation
- 1978-03-14 FR FR7807262A patent/FR2383930A1/fr active Granted
- 1978-03-15 LU LU79235A patent/LU79235A1/de unknown
- 1978-03-15 SU SU782589450A patent/SU799658A3/ru active
- 1978-03-15 DD DD78204190A patent/DD134090A5/xx unknown
- 1978-03-15 BE BE185950A patent/BE864917A/xx not_active IP Right Cessation
- 1978-03-16 ZA ZA00781552A patent/ZA781552B/xx unknown
- 1978-03-16 AT AT0187878A patent/AT364360B/de not_active IP Right Cessation
- 1978-03-16 DK DK118578A patent/DK118578A/da unknown
- 1978-03-16 ES ES467931A patent/ES467931A1/es not_active Expired
- 1978-03-16 YU YU00636/78A patent/YU63678A/xx unknown
- 1978-03-16 CA CA299,068A patent/CA1108148A/en not_active Expired
- 1978-03-16 CS CS781680A patent/CS202011B2/cs unknown
- 1978-03-16 AU AU34195/78A patent/AU525566B2/en not_active Expired
- 1978-03-16 NO NO780931A patent/NO150605C/no unknown
- 1978-03-16 CS CS787593A patent/CS202012B2/cs unknown
- 1978-03-16 HU HU78BA3641A patent/HU177287B/hu not_active IP Right Cessation
- 1978-03-17 JP JP3004178A patent/JPS53116382A/ja active Granted
- 1978-03-17 FI FI780842A patent/FI74962C/fi not_active IP Right Cessation
- 1978-12-19 SU SU782699099A patent/SU850002A3/ru active
-
1980
- 1980-02-15 AT AT0084080A patent/AT364361B/de not_active IP Right Cessation
-
1982
- 1982-10-07 YU YU2252/82A patent/YU41016B/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO784397L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalazin-4-yl-eddiksyrederivater | |
NO147950C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminoalkyl-heterocykliske forbindelser | |
NO144420C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme hydroksansyrer | |
NO154058C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-heterocyklyl-4-piperidinaminer. | |
NO773384L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater | |
NO780883L (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive 4-acylamino-fenyl-etanolaminer | |
NO152651C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 0-substituerte derivater av (+)-cyanidan-3-ol | |
NO150605C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinyl-aminoalkyletere | |
NO147953C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglukosider | |
NO151201C (no) | Fremgangsmaate for fremstilling av terapeutisk virksomme antigenderivater | |
NO781880L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater | |
NO145762C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive antracyklinglykosidiske forbindelser | |
NO152255C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolylvinylethere | |
NO151288C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indolokinolizindiner | |
NO834363L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive sesquiterpenderivater | |
NO151500C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazoloksamsyre-derivater | |
NO781879L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner | |
NO781878L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner. | |
NO149502C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive aminoalkoksyfenylderivater | |
NO151285C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater | |
NO148454C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater | |
NO771884L (no) | Fremgangsm}te for fremstilling av terapeutisk aktive polyribonukleotider | |
NO145843C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme n1-glukofuranosid-6-yl-n3-nitroso-urinstoffer | |
NO151008C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroforbindelser | |
NO780743L (no) | Fremgangsmaate for fremstilling av farmakologisk aktive benzylpyrimidiner |